Literature DB >> 12664882

Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept.

Robert L Elwood1, Mary M Pelszynski, Larry I Corman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12664882

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  10 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

2.  Fever and skin redness in a 10-year-old boy.

Authors:  Sergio T Fenella; Fred Y Aoki
Journal:  CMAJ       Date:  2008-05-20       Impact factor: 8.262

3.  Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment.

Authors:  Kai-Cheng Lin; Chi-Di Liang; Kuender D Yang; Hong-Ren Yu; Ho-Chang Kuo
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

4.  Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-alpha therapy: a case series.

Authors:  Kimberly Morishita; Ross Petty; Robyn Cairns; Roxana Bolaria; David Cabral; Stuart Turvey
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

5.  Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker.

Authors:  Christian Renaud; Philippe Ovetchkine; Patricia Bortolozzi; Claire Saint-Cyr; Bruce Tapiero
Journal:  Eur J Pediatr       Date:  2010-11-10       Impact factor: 3.183

Review 6.  Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.

Authors:  Sima S Toussi; Nancy Pan; Heather M Walters; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 9.079

7.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 8.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

9.  Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Authors:  J B Galloway; K L Hyrich; L K Mercer; W G Dixon; A P Ustianowski; M Helbert; K D Watson; M Lunt; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2011-07-21       Impact factor: 19.103

10.  Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.

Authors:  Mario Abinun; Jonathan P Lane; Mark Wood; Mark Friswell; Terence J Flood; Helen E Foster
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.